In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Dyne Therapeutics Inc (NASDAQ: DYN) closed at $26.08 in the last session, up 0.31% from day before closing price of $26.00. In other words, the price has increased by $0.31 from its previous closing price. On the day, 0.76 million shares were traded. DYN stock price reached its highest trading level at $27.31 during the session, while it also had its lowest trading level at $25.87.
Ratios:
We take a closer look at DYN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.83 and its Current Ratio is at 21.83. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on April 30, 2024, initiated with a Overweight rating and assigned the stock a target price of $40.
On February 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $36.
Raymond James Upgraded its Outperform to Strong Buy on February 27, 2023, whereas the target price for the stock was revised from $16 to $27.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 12 ’24 when Farwell Wildon sold 1,030 shares for $25.58 per share. The transaction valued at 26,347 led to the insider holds 150,560 shares of the business.
Brumm Joshua T sold 66,387 shares of DYN for $1,704,142 on Mar 11 ’24. The CEO & President now owns 537,998 shares after completing the transaction at $25.67 per share. On Mar 11 ’24, another insider, McNeill Jonathan, who serves as the Chief Business Officer of the company, sold 19,601 shares for $25.50 each. As a result, the insider received 499,842 and left with 139,408 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 2278938112 and an Enterprise Value of 1852009216.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $30.27, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is -0.55%, while the 200-Day Moving Average is calculated to be 64.55%.
Shares Statistics:
According to the various share statistics, DYN traded on average about 1.26M shares per day over the past 3-months and 821020 shares per day over the past 10 days. A total of 61.47M shares are outstanding, with a floating share count of 50.99M. Insiders hold about 37.13% of the company’s shares, while institutions hold 58.91% stake in the company. Shares short for DYN as of 1713139200 were 9023636 with a Short Ratio of 7.15, compared to 1710460800 on 6822917. Therefore, it implies a Short% of Shares Outstanding of 9023636 and a Short% of Float of 12.870000000000001.
